Page 3 - Currax Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Currax pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Currax Pharmaceuticals Today - Breaking & Trending Today

Currax Pharmaceuticals: CONTRAVE(R)/MYSIMBA(R) demonstrates no increased risk in major adverse cardiac events in a large, long-term real-world evidence study

Currax Pharmaceuticals LLC(Currax) today announced top-line results from a Cardiovascular Health Outcomes Analysis (HOA). This study evaluated the cardiovascular safety of CONTRAVE(R)/MYSIMBA(R), a weight management drug. The real-world study ....

Michael Kyle , George Hampton , Cardiovascular Health Outcomes Analysis , Drug Administration , Currax Pharmaceuticals , European Medicines Agency , Health Outcomes Analysis , European Union , Chief Medical , Currax President , Health Outcomes , European Economic Area ,

Wegovy, other weight-loss drugs scrutinised over reports of suicidal thoughts

Dawn Heidlebaugh felt trapped in a disturbing pattern while taking Ozempic, the popular drug used to treat diabetes and obesity. Each Sunday for more than a year, the 53-year-old Ohio real estate agent took her weekly injection to help control her blood sugar. Then every Tuesday, she felt lethargic, depressed and sometimes suicidal, thinking her husband and four children might. ....

North Carolina , United States , United Kingdom , New York , Novo Saxenda , Eli Lilly , Lisa Wood , Jayson Chesnutt , Sarah Sobol , John Amos , Thomasj Moore , Oderick Turner , Sanofi Acomplia , Drug Administration , Johns Hopkins Bloomberg School Of Public Health , Currax Pharmaceuticals , Oregon Health Science University , European Union , European Medicines Agency , Novo Nordisk , Dawn Heidlebaugh , Johns Hopkins Bloomberg School , Public Health , Oregon Health ,

Wegovy, other weight-loss drugs scrutinized over reports of suicidal thoughts

“I knew it was the drug,” said Heidlebaugh, who said she had not previously suffered from depression. Heidlebaugh is one of four U.S. patients who told Reuters about experiencing suicidal thoughts while taking Novo Nordisk’s popular Ozempic drug, approved to treat type 2 diabetes, or Wegovy, another Novo top-seller approved for weight loss. A fifth patient said he experienced depression and suicidal thoughts after taking Mounjaro, a similar diabetes medicine from Eli Lilly, which is also used for weight loss. ....

United States , North Carolina , United Kingdom , New York , Novo Saxenda , Brian Thevenot , Maggie Fick , Sarah Sobol , Jayson Chesnutt , Oderick Turner , Robin Respaut , Thomasj Moore , Lisa Wood , John Amos , Eli Lilly , Sanofi Acomplia , Michele Gershberg , Ludwig Burger , European Medicines Agency , Novo Nordisk , Oregon Health Science University , Drug Administration , Currax Pharmaceuticals , Johns Hopkins Bloomberg School Of Public Health , European Union , Johns Hopkins Bloomberg School ,